The U.S. Food and Drug Administration has approved REDEMPLO (plozasiran) from Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) to reduce triglycerides in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE